Top Menu

Federal Government Funding for Marijuana Research Declines

/By

The federal government has been reducing funding for research on marijuana’s potential medical benefits, Bloomberg reports. Medical research funding for marijuana reached a peak of $131 million in 2007; it dropped to $91 million last year.

Studies have suggested marijuana may help stimulate appetite in chemotherapy and AIDS patients, the article notes. Research also has suggested it may help improve muscle spasms in people with multiple sclerosis, reduce nerve pain in people with HIV-related nerve damage, and may reduce anxiety and depression. However, the current medical literature contains contradictory findings on marijuana, leaving doctors who prescribe the drug in states where medical marijuana is legal with little guidance.

“What’s happening in the states is not related to science at all,” said Beau Kilmer, Co-Director of RAND Corp.’s Drug Policy Research Center. “It’s difficult to get good information.”

Colorado and Washington state have legalized the recreational use of marijuana, while medical marijuana is legal in 18 states, the article notes.

Many doctors and policymakers making decisions about marijuana rely on a 1999 report from the Institute of Medicine, which concluded the drug appeared to have benefits, but the drug’s role was unclear. “We don’t know that much more than what’s in that report,” said Donald Vereen, a former adviser to the National Institute on Drug Abuse (NIDA).

The American Medical Association says fewer than 20 randomized controlled clinical trials, involving about 300 patients, have been conducted on smoked marijuana in the past 35 years. NIDA controls the marijuana used in approved studies, but it concentrates on research into the risks of marijuana, not its potential medical benefits.

1 Response to this article

  1. Dave / April 16, 2013 at 5:12 pm

    It “may reduce anxiety and depression”?
    What have you been smoking? The research points in the opposite direction. The only anxiolytic effect is for folks experiencing cannabis withdrawal. Otherwise there is consistent and convincing evidence that it increases anxiety. The only qualification on this is that the
    anxiety effects of cannabis may be somewhat related to individual biology and thus may only be seen in some smokers. But since we don’t know who is susceptible, the best risk prevention strategy for folks who have anxiety is to taper and then abstain from cannabis. In any case cognitive behavioral strategies are less risky and equally effective with anxiolytic meds.
    On the other hand, cannabis seems to be good medicine for chronic pain not just for HIV related. It’s encouraging that Sativex should soon be available in the US for pain issues.

Leave a Reply

Please read our comment policy and guidelines before you submit a comment. Your email address will not be published. Thank you for visiting Drugfree.org


8 − = two

Disclaimer:
Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail jointogether@drugfree.org.